Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth I Ataga

Showing results (101-110 of 133) with videos related to

Pageof 14
Sort By:
American Journal of Hematology|October 9, 2018
Effect of crizanlizumab on pain crises in subgroups of patients with sickle cell disease: A SUSTAIN study analysisAbdullah Kutlar, Julie Kanter, Darla K Liles, et al.
Haematologica|November 12, 2020
Rapid decline in estimated glomerular filtration rate in sickle cell anemia: results of a multicenter pooled analysisKenneth I Ataga, Qingning Zhou, Vimal K Derebail, et al.
Pediatric Blood & Cancer|February 8, 2018
Nephrin as a biomarker of sickle cell glomerulopathy in MalawiJ Brett Heimlich, Godwin Chipoka, Laila Elsherif, et al.
British Journal of Haematology|February 24, 2010
Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studiesRobyn J Barst, Kamal K Mubarak, Roberto F Machado, et al.
International Journal of Public Health|August 2, 2021
Prospective Newborn Screening for Sickle Cell Disease and Other Inherited Blood Disorders in Central MalawiGerald Tegha, Hillary M Topazian, Portia Kamthunzi, et al.
American Journal of Hematology|July 6, 2013
A dose-escalation phase IIa study of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell diseaseAbdullah Kutlar, Marvin E Reid, Adlette Inati, et al.
Annals of Hematology|April 20, 2024
Expert consensus on the management of infusion-related reactions (IRRs) in patients with sickle cell disease (SCD) receiving crizanlizumab: a RAND/UCLA modified Delphi panelJulie Kanter, Kenneth I Ataga, Neha Bhasin, et al.
American Journal of Hematology|August 14, 2019
A pilot study of the effect of atorvastatin on endothelial function and albuminuria in sickle cell diseaseKenneth I Ataga, David Wichlan, Laila Elsherif, et al.
Blood Advances|June 13, 2022
Longitudinal study of glomerular hyperfiltration in adults with sickle cell anemia: a multicenter pooled analysisKenneth I Ataga, Qingning Zhou, Santosh L Saraf, et al.
Haematologica|December 22, 2022
Sex differences in progression of kidney disease in sickle cell diseaseKenneth I Ataga, Qingning Zhou, Santosh L Saraf, et al.
Pageof 14

Showing results (101-110 of 133) with videos related to

Sort By:
Pageof 14
American Journal of Hematology|October 9, 2018
Effect of crizanlizumab on pain crises in subgroups of patients with sickle cell disease: A SUSTAIN study analysisAbdullah Kutlar, Julie Kanter, Darla K Liles, et al.
Haematologica|November 12, 2020
Rapid decline in estimated glomerular filtration rate in sickle cell anemia: results of a multicenter pooled analysisKenneth I Ataga, Qingning Zhou, Vimal K Derebail, et al.
Pediatric Blood & Cancer|February 8, 2018
Nephrin as a biomarker of sickle cell glomerulopathy in MalawiJ Brett Heimlich, Godwin Chipoka, Laila Elsherif, et al.
British Journal of Haematology|February 24, 2010
Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studiesRobyn J Barst, Kamal K Mubarak, Roberto F Machado, et al.
International Journal of Public Health|August 2, 2021
Prospective Newborn Screening for Sickle Cell Disease and Other Inherited Blood Disorders in Central MalawiGerald Tegha, Hillary M Topazian, Portia Kamthunzi, et al.
American Journal of Hematology|July 6, 2013
A dose-escalation phase IIa study of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell diseaseAbdullah Kutlar, Marvin E Reid, Adlette Inati, et al.
Annals of Hematology|April 20, 2024
Expert consensus on the management of infusion-related reactions (IRRs) in patients with sickle cell disease (SCD) receiving crizanlizumab: a RAND/UCLA modified Delphi panelJulie Kanter, Kenneth I Ataga, Neha Bhasin, et al.
American Journal of Hematology|August 14, 2019
A pilot study of the effect of atorvastatin on endothelial function and albuminuria in sickle cell diseaseKenneth I Ataga, David Wichlan, Laila Elsherif, et al.
Blood Advances|June 13, 2022
Longitudinal study of glomerular hyperfiltration in adults with sickle cell anemia: a multicenter pooled analysisKenneth I Ataga, Qingning Zhou, Santosh L Saraf, et al.
Haematologica|December 22, 2022
Sex differences in progression of kidney disease in sickle cell diseaseKenneth I Ataga, Qingning Zhou, Santosh L Saraf, et al.
Pageof 14